ARTICLE SUMMARY:
C. Light Technologies is developing a high-resolution retinal imaging and eye tracking technology that can detect and analyze micron-scale movements in the back of the eye as a noninvasive means of assessing disease severity and progression in patients with multiple sclerosis and other neurological disorders.
Start-up C. Light Technologies Inc. can trace its beginnings to dissertation work performed by company CEO and co-founder Christy Sheehy while a PhD student at the University of California, Berkeley. Sheehy, whose PhD is in Vision Science, developed a unique, high-resolution retinal imaging and eye tracking technology capable of detecting micron-scale involuntary movements in the back of the eye, known as fixational microsaccades, that have been linked to motor dysfunction caused by neurological disease. Sheehy teamed up with another UC Berkeley Vision Science PhD, Zach Helft, and in 2014, the two founded C. Light Technologies—which is part of UC Berkeley’s SkyDeck accelerator—to commercialize the technology.
